CAPTRUST Financial Advisors
ANIX icon

CAPTRUST Financial Advisors’s Anixa Biosciences ANIX Stock Holding History

CAPTRUST Financial Advisors’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5,000
Closed -$15K – 2156
2022
Q2 		$15K Hold
5,000
– – ﹤0.01% 3521
2022
Q1 		$14K Buy
+5,000
New +$14.7K ﹤0.01% 3605
2021
Q4 		– Sell
-2,500
Closed -$12K – 4759
2021
Q3 		$12K Hold
2,500
– – ﹤0.01% 3486
2021
Q2 		$10K Hold
2,500
– – ﹤0.01% 3529
2021
Q1 		$12K Buy
+2,500
New +$11.9K ﹤0.01% 3322

Other funds holding ANIX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CAPTRUST Financial Advisors's ANIX Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Anixa Biosciences (ANIX) in Q3 2022, closing a stake of 5,000 shares — an estimated $15K sold.

CAPTRUST Financial Advisors first reported a position in ANIX in Q1 2021 and held it in 5 quarters. The position peaked at $15K in Q2 2022. 41 funds tracked by Wall St. Rank hold ANIX as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Anixa Biosciences position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 5,000 Anixa Biosciences shares in Q3 2022, an estimated $15K.
  • CAPTRUST Financial Advisors first reported a position in Anixa Biosciences in Q1 2021 and held it in 5 quarters.
  • CAPTRUST Financial Advisors's Anixa Biosciences position peaked at $15K in Q2 2022.
  • 41 funds tracked by Wall St. Rank held Anixa Biosciences as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.